Grant: Engage Grants Program
University of Ottawa
$24,950.00
Clustering of Phytoglycogen Nanoparticles at High Concentrations
FY 2016-17
Summary
Mirexus Biotechnologies Inc produces a trademarked natural nanomaterial called PhytoSpherix, which iscomposed of phyto-glycogen nanoparticles for human use in food, nutraceuticals, cosmetics andpharmaceuticals. One targeted use of these nanoparticles is to encapsulate other valuable ingredients, makingthem soluble in water for increased bioavailability, and stabilizing them against photo and thermal degradation.Understanding how PhytoSpherix nanoparticles in solution associate into clusters and interact with activeingredients is essential to the commercial success of the technology. This proposed ENGAGE research projectwill use three complementary, non-invasive radiation scattering techniques (Diffusing Wave Spectroscopy,Differential Dynamic Microscopy, and X-ray Photon Correlation Spectroscopy) to characterize particleclustering in concentrated, opaque solutions of PhytoSpherix in formulations with and without added modelnutraceutical and pharmaceutical encapsulants. Understanding the concentration-dependent clusteringbehavior of PhytoSpherix alone and in the presence of active ingredients will facilitate the development ofencapsulation capabilities that create value for Mirexus' material in the marketplace. Generating an earlyrevenue stream from sales of PhytoSpherix to nutraceutical, cosmetics and pharmaceutical manufacturers willalso allow Mirexus to hire more people, further invest in R&D, and build a manufacturing plant - all in Canada- and thereby benefit the Canadian biotechnology sector and economy.
Program
Engage Grants Program
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
507468-2016
Name nom
Harden, James
Department département
Physics
Organization id
28
Institution établissement
University of Ottawa
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2016
Competition year année de concours
2016
Award amount
24950
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
3113
Research subject group en
Physics
Research subject group fr
Physique
Research subject en
Biophysics
Research subject fr
Biophysique
Partie
1
Nb partie
1
Application title
Clustering of Phytoglycogen Nanoparticles at High Concentrations
Keyword
NSERC
Application summary
Mirexus Biotechnologies Inc produces a trademarked natural nanomaterial called PhytoSpherix, which iscomposed of phyto-glycogen nanoparticles for human use in food, nutraceuticals, cosmetics andpharmaceuticals. One targeted use of these nanoparticles is to encapsulate other valuable ingredients, makingthem soluble in water for increased bioavailability, and stabilizing them against photo and thermal degradation.Understanding how PhytoSpherix nanoparticles in solution associate into clusters and interact with activeingredients is essential to the commercial success of the technology. This proposed ENGAGE research projectwill use three complementary, non-invasive radiation scattering techniques (Diffusing Wave Spectroscopy,Differential Dynamic Microscopy, and X-ray Photon Correlation Spectroscopy) to characterize particleclustering in concentrated, opaque solutions of PhytoSpherix in formulations with and without added modelnutraceutical and pharmaceutical encapsulants. Understanding the concentration-dependent clusteringbehavior of PhytoSpherix alone and in the presence of active ingredients will facilitate the development ofencapsulation capabilities that create value for Mirexus' material in the marketplace. Generating an earlyrevenue stream from sales of PhytoSpherix to nutraceutical, cosmetics and pharmaceutical manufacturers willalso allow Mirexus to hire more people, further invest in R&D, and build a manufacturing plant - all in Canada- and thereby benefit the Canadian biotechnology sector and economy.